We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Article |

FDA approves lithotripter for kidney stone shattering

Charles Marnick; Phil Gunby
JAMA. 1985;253(5):620-623. doi:10.1001/jama.1985.03350290018003.
Text Size: A A A
Published online


The Food and Drug Administration has approved an ultrasonic kidney stone shattering device (JAMA [MEDICAL NEWS] 1983;249:2434-2435).

This version of the device, technically called a lithotripter, was recommended for approval last May after extensive review of the clinical data by the FDA's advisory panel on gastroenterological and urological devices. The FDA commissioner acted on this advice just before the new year.

This lithotripter has been used in treating some 10,000 patients with kidney stones in studies over the past five years in West Germany, as well as in several centers in the United States over the last year and a half. Currently, six centers in the United States have the device. The lithotripter was originally developed in West Germany by Dornier System of Friedrichshafen.

The FDA has approved the lithotripter for treating stones formed in the renal calyx, pelvis, and upper third of the ureter. It is not suitable for


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?




Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.